Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Everest Medicines
274
Everest Medicines
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Everest Medicines, a Chinese innovative biopharmaceutical company
Suggest edits
Raised
$310M
Companies in the same industry
Pharmapod
G-CON
VG Life Sciences
Mycodev Group
Atlantic Healthcare plc
PeptiMimesis
Fulgent Diagnostics
Madrigal Pharmaceuticals Inc.
DelMar Pharma
Verona Pharma Plc
Overview
Funding
1
Add info
Latest funding
$310,000,000
Venture capital (Series C) - 2020
RA Capital Management
Rock Springs Capital
Hillhouse Capital
+5
Team Size
1–10
Employees
I work here
Location
China
Headquarters
Explore China
DealStreetAsia
Chinese biopharma firm Everest Medicines raises $451m in HK IPO
$310,000,000
Venture capital (Series C)
ChinaMoneyNetwork
CBC Group-incubated Everest Medicines Completes $310M Series C Round – China Money Network
